MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 976-981

  Li, Shiqi ^a   Xu, Xianglai ^a   Xu, Xin ^a   Hu, Zhenghui ^a   Wu, Jian ^a   Zhu, Yi ^a   Chen, Hong ^a   Mao, Yeqing ^a   Lin, Yiwei ^a   Luo, Jindan ^a   Zheng, Xiangyi ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bladder cancer; C Fos; MiR 490 5p; Proliferation

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 490 5P; PROTEIN C FOS; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SYNTHESIS; TUMOR SUPPRESSOR GENE;

BLADDER CANCER; C-FOS; MIR-490-5P; PROLIFERATION;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HUMANS; LUCIFERASES; MICRORNAS; PROTO-ONCOGENE PROTEINS C-FOS; URINARY BLADDER NEOPLASMS;

EID: 84888844944     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.11.006     Document Type: Article

References (26)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. Ploeg M., Aben K.K., Kiemeney L.A. The present and future burden of urinary bladder cancer in the world. World J. Urol. 2009, 27:289-293.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Catto J.W., Alcaraz A., Bjartell A.S., De Vere White R., Evans C.P., Fussel S., Hamdy F.C., Kallioniemi O., Mengual L., Schlomm T., Visakorpi T. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 2011, 59:671-681.
5. Fendler A., Stephan C., Yousef G.M., Jung K. MicroRNAs as regulators of signal transduction in urological tumors. Clin. Chem. 2011, 57:954-968.
6. Lin T., Dong W., Huang J., Pan Q., Fan X., Zhang C., Huang L. MicroRNA-143 as a tumor suppressor for bladder cancer. J. Urol. 2009, 181:1372-1380.
7. Lin Y., Chen H., Hu Z., Mao Y., Xu X., Zhu Y., Xu X., Wu J., Li S., Mao Q., Zheng X., Xie L. MiR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. FEBS Lett. 2013, 587:2467-2473.
8. Lin Y., Wu J., Chen H., Mao Y., Liu Y., Mao Q., Yang K., Zheng X., Xie L. Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBS Lett. 2012, 586:442-447.
9. Majid S., Dar A.A., Saini S., Deng G., Chang I., Greene K., Tanaka Y., Dahiya R., Yamamura S. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS ONE 2013, 8:e67686.
10. Mo M., Peng F., Wang L., Peng L., Lan G., Yu S. Roles of mitochondrial transcription factor A and microRNA-590-3p in the development of bladder cancer. Oncol. Lett. 2013, 6:617-623.
11. Han Y., Chen J., Zhao X., Liang C., Wang Y., Sun L., Jiang Z., Zhang Z., Yang R., Chen J., Li Z., Tang A., Li X., Ye J., Guan Z., Gui Y., Cai Z. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE 2011, 6:e18286.
12. Allegra A., Alonci A., Campo S., Penna G., Petrungaro A., Gerace D., Musolino C. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer. Int. J. Oncol. 2012, 41:1897-1912.
13. Osaki M., Takeshita F., Ochiya T. MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 2008, 13:658-670.
14. Sotillo E., Thomas-Tikhonenko A. Shielding the messenger (RNA): microRNA-based anticancer therapies. Pharmacol. Ther. 2011, 131:18-32.
15. Schaefer A., Stephan C., Busch J., Yousef G.M., Jung K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat. Rev. Urol. 2010, 7:286-297.
16. Pignot G., Cizeron-Clairac G., Vacher S., Susini A., Tozlu S., Vieillefond A., Zerbib M., Lidereau R., Debre B., Amsellem-Ouazana D., Bieche I. MicroRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int. J. Cancer 2013, 132:2479-2491.
17. Zaravinos A., Radojicic J., Lambrou G.I., Volanis D., Delakas D., Stathopoulos E.N., Spandidos D.A. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. J. Urol. 2012, 188:615-623.
18. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 1997, 9:240-246.
19. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4:E131-136.
20. Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 2005, 41:2449-2461.
21. Saez E., Rutberg S.E., Mueller E., Oppenheim H., Smoluk J., Yuspa S.H., Spiegelman B.M. C-fos is required for malignant progression of skin tumors. Cell 1995, 82:721-732.
22. Sunters A., McCluskey J., Grigoriadis A.E. Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation. Dev. Genet. 1998, 22:386-397.
23. Bamberger A.M., Milde-Langosch K., Rossing E., Goemann C., Loning T. Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators. J. Cancer Res. Clin. Oncol. 2001, 127:545-550.
24. Hour T.C., Pu Y.S., Lin C.C., Huang S.W., Chen J., Chiu A.W., Chen C.J., Huang C.Y. Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer. Anticancer Res. 2006, 26:375-378.
25. Simeonova P.P., Wang S., Toriuma W., Kommineni V., Matheson J., Unimye N., Kayama F., Harki D., Ding M., Vallyathan V., Luster M.I. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 2000, 60:3445-3453.
26. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400.